InvestSMART

Imricor Medical Systems Inc (ASX: IMR) - Announcements

Current share price for IMR : $1.280 0.03 (2.29%)+

ASX company news and announcements for Imricor Medical Systems Inc (IMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imricor Medical Systems Inc (IMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imricor Medical Systems Inc (IMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imricor Medical Systems Inc (IMR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$459 Application for quotation of securities - IMR 27 Mar 2025 11:56AM $1.660 $1.280 fallen by 22.89%
$459 Application for quotation of securities - IMR 26 Mar 2025 2:49PM $1.600 $1.280 fallen by 20%
$459 Reinstatement to Official Quotation 20 Mar 2025 9:39AM $1.410 $1.280 fallen by 9.22%
$459 Equity Raising Presentation 20 Mar 2025 9:39AM $1.410 $1.280 fallen by 9.22%
$459 Proposed issue of securities - IMR 20 Mar 2025 9:39AM $1.410 $1.280 fallen by 9.22%
$459 Successful Completion of A$70 Million Capital Raise 20 Mar 2025 9:38AM $1.410 $1.280 fallen by 9.22%
$459 Suspension from Quotation 19 Mar 2025 9:27AM $1.410 $1.280 fallen by 9.22%
$459 Trading Halt 17 Mar 2025 9:47AM $1.410 $1.280 fallen by 9.22%
$459 S&P DJI Announces March 2025 Quarterly Rebalance 7 Mar 2025 5:01PM $1.560 $1.280 fallen by 17.95%
$459 Submission of Second Module to FDA for PMA Products 4 Mar 2025 9:27AM $1.580 $1.280 fallen by 18.99%
$459 FY24 Results Investor Presentation 27 Feb 2025 8:07AM $1.460 $1.280 fallen by 12.33%
$459 Imricor Releases FY24 Results 27 Feb 2025 8:07AM $1.460 $1.280 fallen by 12.33%
$459 Appendix 4E and FY24 Financial Accounts 27 Feb 2025 8:06AM $1.460 $1.280 fallen by 12.33%
$459 CE Mark Approval for 2nd Gen Vision MR Ablation Catheter 19 Feb 2025 9:16AM $1.480 $1.280 fallen by 13.51%
$459 FY24 Results Webinar 17 Feb 2025 9:25AM $1.450 $1.280 fallen by 11.72%
$459 Cleansing Notice 7 Feb 2025 1:21PM $1.290 $1.280 fallen by 0.78%
$459 Application for quotation of securities - IMR 7 Feb 2025 1:16PM $1.285 $1.280 fallen by 0.39%
$459 Release from Voluntary Escrow 31 Jan 2025 10:01AM $1.420 $1.280 fallen by 9.86%
$459 Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C 23 Jan 2025 9:01AM $1.335 $1.280 fallen by 4.12%
$459 Notification regarding unquoted securities - IMR 13 Jan 2025 9:30AM $1.245 $1.280 risen by 2.81%
$459 Notification of cessation of securities - IMR 9 Jan 2025 12:18PM $1.230 $1.280 risen by 4.07%
$459 Clarification Announcement 31 Dec 2024 9:25AM $1.305 $1.280 fallen by 1.92%
$459 Imricor Received First Purchase Order in the Middle East 30 Dec 2024 9:04AM $1.170 $1.280 risen by 9.40%
$459 NorthStar Regulatory Update 23 Dec 2024 8:44AM $1.025 $1.280 risen by 24.88%
$459 Imricor Signs License Agreement with ADIS for Northstar 28 Nov 2024 9:29AM $1.070 $1.280 risen by 19.63%

126 - 150 of 606 results

Page 6 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.